Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Early Detection of Breast Cancer with AI enhanced workflows Dr. Tariq Mahmood Institute of Business Administration PLCO Mar 13, 2024 PLCO-1496
Segmentation of future lung cancer from LDCT screening scans. Daniel Truhn Department of Diagnostic and Interventional Radiology of the University Hospital Aachen (Germany) NLST Mar 12, 2024 NLST-1207
The utility of CT-based nodule characteristics and polygenic risk score in the setting of a lung cancer screening trial. Gerard Silvestri Medical University of South Carolina NLST Mar 11, 2024 NLST-1201
Anomaly Detection in Lung CT Scans through AWS SageMaker: A Machine Learning Approach Emma Kang University of California at Berkeley NLST Mar 11, 2024 NLST-1202
Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification Corey Arnold University of California, Los Angeles PLCO Mar 11, 2024 PLCOI-1492
Feasibility of colorectal and lung cancer screening using machine learning towards effective screening and early detection Sujin Kim University of Kentucky NLST Feb 29, 2024 NLST-1200
Assess positive-sum fairness of CXR classifiers leveraging demographic attributes Samia Belhadj Lunit Inc. PLCO Feb 27, 2024 PLCO-1490
Alcohol intake and the risk of colorectal adenomas and colorectal cancer in the PLCO (NCI Version) Erikka Loftfield (240)762-3319 PLCO Feb 27, 2024 PLCO-1489
Validation of a multimodal generative model for lung cancer and tuberculosis detection on chest radiograph in screening population Amy Hong Kakaobrain NLST Feb 26, 2024 NLST-1197
Long-Term Mortality Patterns Following Lung Cancer Subtype Resections: A Comparative Analysis of NLST Data Christopher Towe Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University NLST Feb 26, 2024 NLST-1196
Reassessing Efficacy: Understanding Failures in Lung Cancer Screening Despite Low-Dose CT Protocol Adherence Christopher Towe Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University NLST Feb 26, 2024 NLST-1195
Ethnic and molecular diversity in prostate cancer Lisa Smith University of Nebraska at Omaha PLCO Feb 26, 2024 PLCO-1488
Characterizing polyp progression and its relationship to colorectal cancer in a longitudinal study Scott Lipnick Flagship Labs LLC PLCO Feb 26, 2024 PLCO-1485
Types of Physical Activity, Sedentary Behavior and Risk of Cancer and Mortality: Pooled Analyses in the NCI Cohort Consortium Steven Moore National Cancer Institute PLCO Feb 26, 2024 PLCO-1483
Development of Medical AI for Cancer Diagnosis and Area Detection hyunwoo kim VUNO PLCO Feb 26, 2024 PLCOI-1484
Development of non-invasive biomarkers to assess disease progression using patients diagnostic imaging and clinical data Yoganand Balagurunathan H Lee Moffitt Cancer Center and Research Institute PLCO Feb 26, 2024 PLCOI-1469
Is there a correlation between the age of the diagnosed prostate cancer patient and initial PSA result and final staging Alistair Wright Open University PLCO Feb 26, 2024 PLCO-1482
Examining the performance of weighting methods under different populations Lei Song George Washington University PLCO Feb 15, 2024 PLCO-1480
The Impact of Location of Colon Polyps at Colonoscopy on Risk of Colorectal Cancer Incidence and Mortality: Secondary Analyses of the PLCO Trial Paolo Goffredo University of Minnesota PLCO Feb 14, 2024 PLCO-1465
Mobile Based Breast Cancer Diagnosing System Using a Rough Set-Ensemble Classifier Approach Arthur Rahming Philander Smith University PLCO Feb 14, 2024 PLCO-1478